ClinicalTrials.gg
RecruitingNCT07619651Updated Jun 25, 2026

Comparison of Sacral ESP Block and Caudal Block in Pediatric Hypospadias Surgery

An interventional study of Sacral ESP Block and Caudal Epidural Block in Hypospadias and Postoperative Pain, sponsored by TC Erciyes University. Recruiting at 1 site in Turkey (Türkiye). Open to male participants aged 6 Months to 7 Years. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by TC Erciyes University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2026, registered May 2026).
  • Started Jan 2026; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
6 Months to 7 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 12 studies in Hypospadias with a site in Turkey — 3 open to participants now, 3 under way, none of them phase 3. Hypospadias · Turkey.

Started
2026
with 1 other
No phase
8 of 12
3 open now
Registered
10th of 12
by date
Lead sponsor
1 of 12
TC Erciyes University

Among the 12 studies in Hypospadias with a site in Turkey, this one is one of 2 that started in 2026, is one of 8 with no phase, and was the 10th registered.

Hypospadias

123 studies on the registry are indexed under Hypospadias; 34 are open to participants now.

Browse Hypospadias studies →

Open to participants now

3 of the 12 studies in Hypospadias with a site in Turkey are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 20 Hypospadias studies recruiting now, 4 (20%) set no upper age limit and 16 (80%) stop at 75 or younger; 18 take children under 18; 3 take healthy volunteers.

This study: 6 Months to 7 Years · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Hypospadias with a site in Turkey, or all of them as a file.
02

Study summary

Hypospadias surgery in pediatric patients requires effective postoperative analgesia to ensure patient comfort and reduce perioperative stress. Caudal epidural block is widely used for analgesia in pediatric urological procedures; however, alternative regional techniques such as the sacral erector spinae plane (ESP) block have recently gained attention.

This prospective comparative study aims to compare the analgesic efficacy of sacral ESP block and caudal epidural block in pediatric patients undergoing hypospadias surgery. Participants will be allocated to receive either sacral ESP block or caudal epidural block according to the study protocol.

The primary outcome will be postoperative pain scores within the first 24 hours after surgery. Secondary outcomes will include total analgesic consumption, time to first rescue analgesia, and block-related complications.

Read the detailed description

Hypospadias is one of the most common congenital urogenital anomalies in pediatric patients and typically requires surgical correction in early childhood. Effective postoperative pain management is essential to improve patient comfort, reduce perioperative stress, and prevent complications. Inadequate pain control in pediatric surgical patients has been associated with increased morbidity, prolonged hospital stay, and delayed recovery.

Caudal epidural block is widely used for postoperative analgesia in pediatric urological surgery due to its ease of application and high success rate. However, it has limitations such as relatively short duration of analgesia and potential side effects including motor block, urinary retention, and lower extremity weakness. Therefore, alternative regional anesthesia techniques that may provide longer-lasting analgesia with fewer side effects are of increasing interest.

The erector spinae plane (ESP) block is a relatively novel regional anesthesia technique that provides both somatic and visceral analgesia and can be applied at different spinal levels. The sacral approach to ESP block has recently been described as a potential alternative for lower abdominal and urogenital surgeries. However, evidence regarding its effectiveness in pediatric hypospadias surgery remains limited.

This prospective comparative study aims to compare the analgesic efficacy, postoperative analgesic requirements, and block-related complications of sacral erector spinae plane block and caudal epidural block in pediatric patients undergoing hypospadias repair surgery.

Patients aged between 6 months and 7 years with ASA physical status I-II scheduled for hypospadias repair will be included. Participants will be allocated into either the sacral ESP block group or the caudal epidural block group according to the study protocol.

All patients will receive standardized general anesthesia and monitoring. Regional blocks will be performed under general anesthesia prior to surgery. In the sacral ESP block group, the block will be performed under ultrasound guidance using an in-plane technique, and 0.25% bupivacaine at a dose of 0.5 mL/kg will be administered. In the caudal epidural block group, the block will be performed using a standard technique with 0.25% bupivacaine at a dose of 0.5 mL/kg.

Postoperative pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) scale at 30 minutes, and at 1, 4, 12, and 24 hours after surgery. Total postoperative analgesic consumption, time to first rescue analgesia, and block-related complications (including motor weakness, nausea and vomiting, hypotension, bradycardia, pruritus, intravascular injection, and bleeding) will be recorded.

Statistical analysis will be performed using appropriate tests according to data distribution, with a significance level set at p \< 0.05.

03

Conditions studied

  • Hypospadias
  • Postoperative Pain

Keywords

  • Sacral Erector Spinae Plane Block
  • Caudal Epidural Block
  • Hypospadias Surgery
  • Postoperative Analgesia
  • Pediatric Urology
04

Who can participate

Ages eligible
6 Months to 7 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male patients aged between 6 months to 7 years
  2. Scheduled for hypospadias repair surgery
  3. I-II
  4. No known allergy to local anesthetic agents
  5. No to peripheral nerve blocks
  6. Written obtained from parents or legal guardians

Exclusion criteria

Exclusion Criteria:

  1. Known congenital coagulopathy
  2. Known allergy to local anesthetic agents
  3. Severe systemic disease ()
  4. Severe organ failure
  5. Neurological disorders
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Sacral ESP Block Group

    Patients receiving ultrasound-guided sacral erector spinae plane block for postoperative analgesia

    Procedure: Sacral ESP Block

  • Active comparator
    Caudal Epidural Block Group

    Patients receiving caudal epidural block for postoperative analgesia

    Procedure: Caudal Epidural Block

Interventions

  • ProcedureSacral ESP Block

    Sacral erector spinae plane block will be performed under ultrasound guidance in pediatric patients under general anesthesia. A linear ultrasound probe will be placed in the longitudinally over the sacral region to identify the sacral median crest and erector spinae muscle. Using an in-plane technique, a block needle will be advanced in a cranial-to-caudal direction, and after negative aspiration, 0.25% bupivacaine at a dose of 0.5 mL/kg will be injected beneath the erector spinae muscle at the level of the sacral vertebra. The injection will be performed incrementally with intermittent aspiration to avoid intravascular injection.

  • ProcedureCaudal Epidural Block

    Caudal epidural block will be performed in pediatric patients under general anesthesia in the lateral decubitus position. The sacrococcygeal membrane will be identified using anatomical landmarks, and a needle will be inserted into the caudal epidural space. After negative aspiration, 0.25% bupivacaine at a dose of 0.5 mL/kg will be administered slowly. Intermittent aspiration will be performed during injection to minimize the risk of intravascular or intrathecal injection.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Score Assessed by FLACC Scale

    Postoperative pain intensity will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale in pediatric patients undergoing hypospadias repair surgery. The FLACC scale consists of five behavioral categories (Face, Legs, Activity, Cry, Consolability), each scored from 0 to 2 points, resulting in a total score ranging from 0 to 10. Higher scores indicate greater pain intensity. FLACC scores will be recorded at 30 minutes, and at 1, 4, 12, and 24 hours after surgery. Rescue analgesia will be administered when the FLACC score is 4 or greater.

    Time frame: Within the first 24 hours after surgery

Secondary outcomes

  1. Time to First Rescue Analgesia

    Time from the end of surgery to the first administration of rescue analgesic medication will be recorded.

    Time frame: Within the first 24 hours after surgery

  2. Total Postoperative Analgesic Consumption

    Total amount of analgesic medications required within the first 24 hours after surgery will be recorded.

    Time frame: Within the first 24 hours after surgery

  3. Block-Related Complications

    Block-related complications including motor weakness, nausea and vomiting, hypotension, bradycardia, pruritus, intravascular injection, and bleeding will be assessed.

    Time frame: Within the first 24 hours after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Tulgar S, Senturk O, Thomas DT, Deveci U, Ozer Z. A new technique for sensory blockage of posterior branches of sacral nerves: Ultrasound guided sacral erector spinae plane block. J Clin Anesth. 2019 Nov;57:129-130. doi: 10.1016/j.jclinane.2019.04.014. Epub 2019 Apr 15. No abstract available. PubMed 30999197 ↗
  • Sancak Demirci NB, Kesici S, Oba S, Turk HS, Cinar AS, Demir M. Comparison of analgesic efficacy of sacral erector spinae plane block and caudal block in pediatric patients undergoing hypospadias repair surgery. J Pediatr Urol. 2025 Aug;21(4):885-893. doi: 10.1016/j.jpurol.2025.03.010. Epub 2025 Mar 20. PubMed 40180872 ↗
  • Kaya C, Dost B, Tulgar S. Sacral Erector Spinae Plane Block Provides Surgical Anesthesia in Ambulatory Anorectal Surgery: Two Case Reports. Cureus. 2021 Jan 9;13(1):e12598. doi: 10.7759/cureus.12598. PubMed 33585088 ↗
  • Bansal T, Yadav N, Singhal S, Kadian Y, Lal J, Jain M. Evaluation of USG-guided novel sacral erector spinae block for postoperative analgesia in pediatric patients undergoing hypospadias repair: A randomized controlled trial. J Anaesthesiol Clin Pharmacol. 2024 Apr-Jun;40(2):330-335. doi: 10.4103/joacp.joacp_418_22. Epub 2023 Jul 29. PubMed 38919450 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Sep 2026, 7 months after the start.

Of 60 non-industry interventional studies with no phase under Hypospadias, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's planned 7 months is below that.

Counting every sponsor, half of 60 studies reached it within 15 months; a quarter within 8 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
May 4, 2026
First posted
Jun 2, 2026
StartActual
Jan 5, 2026
Primary completionEst.
Sep 1, 2026
CompletionEst.
Nov 1, 2026
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07619651
Responsible party
Özlem ÖZ GERGİN (Principal Investigator, TC Erciyes University) — Principal investigator
First posted
Jun 2, 2026
Start date
Jan 5, 2026
Primary completion
Sep 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Jun 25, 2026

Study contacts

ÖZLEM ÖZ GERGİN, MD
Contact
oozgergin@erciyes.edu.tr
0905332466396
RABİA BÜŞRA SATICI, MD
Contact
rabiaoztoprak@erciyes.edu.tr
0905548846343
ÖZLEM ÖZ GERGİN
principal investigator · Erciyes University Faculty of Medicine
RABİA BÜŞRA SATICI
study director · Erciyes University Faculty of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion